Skip to Content

Immune Globulin Subcutaneous Dosage

Applies to the following strength(s): 160 mg/mL ; 20%

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Primary Immunodeficiency Syndrome

Begin treatment one week after receiving a regularly scheduled IGIV infusion.
Initial dose: calculated by multiplying the previous IGIV dose by 1.37, then dividing this dose into weekly doses based on the patient's previous IGIV treatment, administered subcutaneously; for example, if IGIV was administered every three weeks, divide by 3.

Recommended weekly doses: 100 to 200 mg/kg body weight subcutaneously.

Usual Pediatric Dose for Primary Immunodeficiency Syndrome

Begin treatment one week after receiving a regularly scheduled IGIV infusion.
>=2 years:
Initial dose: calculated by multiplying the previous IGIV dose by 1.37, then dividing this dose into weekly doses based on the patient's previous IGIV treatment, administered subcutaneously; for example, if IGIV was administered every three weeks, divide by 3.

Recommended weekly doses: 100 to 200 mg/kg body weight subcutaneously.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dose Adjustments

Dosage may be adjusted to achieve desired clinical response and serum IgG levels.

Precautions

Immune globulin subcutaneous is contraindicated in patients with selective immunoglobulin A (IgA) deficiency (serum IgA <0.05 g/L) who have known antibody against IgA.

Do not inject intravenously.

Dialysis

Data not available

Hide